Literature DB >> 28397097

Blood-Brain Barriers in Obesity.

Elizabeth M Rhea1,2, Therese S Salameh3,4, Aric F Logsdon3,4, Angela J Hanson3,4, Michelle A Erickson3,4, William A Banks3,4.   

Abstract

After decades of rapid increase, the rate of obesity in adults in the USA is beginning to slow and the rate of childhood obesity is stabilizing. Despite these improvements, the obesity epidemic continues to be a major health and financial burden. Obesity is associated with serious negative health outcomes such as cardiovascular disease, type II diabetes, and, more recently, cognitive decline and various neurodegenerative dementias such as Alzheimer's disease. In the past decade, major advancements have contributed to the understanding of the role of the central nervous system (CNS) in the development of obesity and how peripheral hormonal signals modulate CNS regulation of energy homeostasis. In this article, we address how obesity affects the structure and function of the blood-brain barrier (BBB), the impact of obesity on Alzheimer's disease, the effects of obesity on circulating proteins and their transport into the brain, and how these changes can potentially be reversed by weight loss.

Entities:  

Keywords:  blood-brain barrier; insulin; leptin; obesity

Mesh:

Substances:

Year:  2017        PMID: 28397097      PMCID: PMC5972029          DOI: 10.1208/s12248-017-0079-3

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  122 in total

1.  Central administration of oleic acid inhibits glucose production and food intake.

Authors:  Silvana Obici; Zhaohui Feng; Kimyata Morgan; Daniel Stein; George Karkanias; Luciano Rossetti
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

Review 2.  Insulin and the blood-brain barrier.

Authors:  Stephen C Woods; Randy J Seeley; Denis G Baskin; Michael W Schwartz
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

3.  Impaired transport of leptin across the blood-brain barrier in obesity.

Authors:  W A Banks; C R DiPalma; C L Farrell
Journal:  Peptides       Date:  1999-11       Impact factor: 3.750

4.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

5.  Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

Authors:  David A Elliott; Cyndi Shannon Weickert; Brett Garner
Journal:  Clin Lipidol       Date:  2010-08-01

6.  Glucose and insulin increase the transport of leptin through the blood-brain barrier in normal mice but not in streptozotocin-diabetic mice.

Authors:  A J Kastin; V Akerstrom
Journal:  Neuroendocrinology       Date:  2001-04       Impact factor: 4.914

7.  Adiponectin acts in the brain to decrease body weight.

Authors:  Yong Qi; Nobuhiko Takahashi; Stanley M Hileman; Hiralben R Patel; Anders H Berg; Utpal B Pajvani; Philipp E Scherer; Rexford S Ahima
Journal:  Nat Med       Date:  2004-04-11       Impact factor: 53.440

8.  Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.

Authors:  Miles C Miller; Rosemarie Tavares; Conrad E Johanson; Virginia Hovanesian; John E Donahue; Liliana Gonzalez; Gerald D Silverberg; Edward G Stopa
Journal:  Brain Res       Date:  2008-07-14       Impact factor: 3.252

9.  Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Authors:  T J Kieffer; C H McIntosh; R A Pederson
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

10.  Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation.

Authors:  Pratibha V Nerurkar; Lisa M Johns; Lance M Buesa; Gideon Kipyakwai; Esther Volper; Ryuei Sato; Pranjal Shah; Domonkos Feher; Philip G Williams; Vivek R Nerurkar
Journal:  J Neuroinflammation       Date:  2011-06-03       Impact factor: 8.322

View more
  32 in total

Review 1.  Systemic Oxidative Stress: A key Point in Neurodegeneration - A Review.

Authors:  E E Martínez Leo; M R Segura Campos
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

2.  Pursuing the Molecular Nexus Connecting Diabetes and the Associated Cognitive Impairments.

Authors:  Daniel J Torres; Naghum Alfulaij; Alexandru R Sasuclark; Lígia M Watanabe; Herena Y Ha
Journal:  J Neurosci       Date:  2019-10-30       Impact factor: 6.167

3.  Magnetic resonance assessment of the cerebral alterations associated with obesity development.

Authors:  Blanca Lizarbe; Basilio Campillo; Irene Guadilla; Pilar López-Larrubia; Sebastián Cerdán
Journal:  J Cereb Blood Flow Metab       Date:  2020-07-23       Impact factor: 6.200

Review 4.  Prolonging healthy aging: Longevity vitamins and proteins.

Authors:  Bruce N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-15       Impact factor: 11.205

Review 5.  Breakdown of the blood-brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders?

Authors:  Corey J Frank; Ewan C McNay
Journal:  J Neuroendocrinol       Date:  2021-12-13       Impact factor: 3.627

Review 6.  The Blood-Brain Barrier: Much More Than a Selective Access to the Brain.

Authors:  Fredy Sanchez-Cano; Luisa C Hernández-Kelly; Arturo Ortega
Journal:  Neurotox Res       Date:  2021-10-22       Impact factor: 3.911

Review 7.  Legend of Weight Loss: a Crosstalk Between the Bariatric Surgery and the Brain.

Authors:  Ziwei Lin; Shen Qu
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

8.  Does obesity-associated insulin resistance affect brain structure and function of adolescents differentially by sex?

Authors:  Andrea Gabay; Stephanie London; Kathy F Yates; Antonio Convit
Journal:  Psychiatry Res Neuroimaging       Date:  2021-11-24       Impact factor: 2.376

9.  A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients.

Authors:  Alain Bousquet-Mélou; Anne Lespine; Jean-François Sutra; Isabelle Bargues; Pierre-Louis Toutain
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

Review 10.  SARS-CoV-2: is there neuroinvasion?

Authors:  Conor McQuaid; Molly Brady; Rashid Deane
Journal:  Fluids Barriers CNS       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.